⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL600714 | 1.00 | — | — | |
| SCHEMBL27800247 | 1.00 | — | — | |
| SCHEMBL8687592 | 0.84 | GGT1 (0.65) | — | |
| SCHEMBL21663996 | 0.80 | — | — | |
| SCHEMBL62882 | 0.79 | — | — | |
| SCHEMBL64140 | 0.79 | — | — | |
| SCHEMBL8688802 | 0.79 | ARG2 (0.72) | — | |
| SCHEMBL62881 | 0.79 | — | — | |
| SCHEMBL1818554 | 0.77 | GGT1 (0.58) | — | |
| Hydrochloric Acid SCHEMBL1132932 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3423075-B1 | STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION | DANA FARBER CANCER INST INC (US) | 2024-04-03 | — | — | EP | disclosed |
| US-11945846-B2 | Stapled intracellular-targeting antimicrobial peptides to treat infection | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| EP-3317294-B1 | STABILIZED ANTI-MICROBIAL PEPTIDES | DANA FARBER CANCER INST INC (US) | 2023-03-15 | — | — | EP | disclosed |
| US-20200308236-A1 | STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION | DANA-FARBER CANCER INSTITUTE, INC. | 2020-10-01 | — | — | US | disclosed |
| US-20200231638-A1 | STABILIZED ANTI-MICROBIAL PEPTIDES | DANA-FARBER CANCER INSTITUTE, INC. | 2020-07-23 | — | — | US | disclosed |
| US-10464975-B2 | Stabilized anti-microbial peptides | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2019-11-05 | — | — | US | disclosed |
| US-20190292224-A1 | TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. | 2019-09-26 | — | — | US | disclosed |
| US-10328117-B2 | Bis-sulfhydryl macrocyclization systems | AILERON THERAPEUTICS, INC. (US) | 2019-06-25 | — | — | US | disclosed |
| US-20190185518-A9 | WARHEAD-CONTAINING PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF BFL-1 | AILERON THERAPEUTICS, INC. | 2019-06-20 | — | — | US | disclosed |
| US-10300109-B2 | Peptidomimetic macrocycles | AILERON THERAPEUTICS, INC. (US) | 2019-05-28 | — | — | US | disclosed |
| CN-101636407-A | Bimercapto macrocyclization system | AILERON THERAPEUTICS INC (US) | 2010-01-27 | — | — | CN | disclosed |
| US-20090326192-A1 | BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2009-12-31 | — | — | US | disclosed |
| WO-2009149214-A2 | COMPOSITIONS AND METHODS FOR ENHANCING CELLULAR TRANSPORT OF BIOMOLECULES | AILERON THERAPEUTICS, INC. (US) | 2009-12-10 | — | — | WO | disclosed |
| US-20090275519-A1 | Therapeutic peptidomimetic macrocycles | AILERON THERAPEUTICS, INC. (US) | 2009-11-05 | — | — | US | disclosed |
| WO-2009126292-A2 | BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2009-10-15 | — | — | WO | disclosed |
| EP-2094721-A1 | BIS-SULFHYDRYL MACROCYCLIZATION SYSTEMS | Aileron Therapeutics, Inc. (US) | 2009-09-02 | — | — | EP | disclosed |
| WO-2009099677-A2 | THERAPEUTIC PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| US-20090088553-A1 | Bis-Sulfhydryl Macrocyclization Systems | AILERON THERAPEUTICS, INC., A DELAWARE CORPORATION (US) | 2009-04-02 | — | — | US | disclosed |
| US-20090047711-A1 | BIS-SULFHYDRYL MACROCYCLIZATION SYSTEMS | AILERON THERAPEUTICS, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| WO-2008076904-A1 | BIS-SULFHYDRYL MACROCYCLIZATION SYSTEMS | AILERON THERAPEUTICS, INC. (US) | 2008-06-26 | — | — | WO | disclosed |